The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG

Deutsche Bank Deutsche Bank AG, Hong Kong Branch Level 60 International Commerce Centre 1 Austin Road West Kowloon, Hong Kong SAR 26 August 2026 1. Department of Corporate Services, BSE Limited Floor 25, P J Towers, Dalal Street, Mumbai - 400 001 2. National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 3. CC: Piramal Pharma Limited Ground Floor, Piramal Ananta, Agastya Corporate Park, Kamani Junction, LBS Marg, Kurla (West), Mumbai, Maharashtra – 400070 Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir/Ma’am, We write in our capacity as pledgee for the Pledged Shares (as defined below) of Piramal Pharma Limited pledged in our favour by CA Alchemy Investments. Enclosed is a disclosure by Deutsche Bank AG, Mumbai Branch (“Onshore Security Agent”) under Regulation 29 (2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the “Takeover Code”). This disclosure is in addition to our disclosure dated 30 May 2024 (“Earlier Disclosure 1”) and 17 August 2026 (“Earlier Disclosure 2”) under Regulation 29(2) of the Takeover Code. In the Earlier Disclosure 1, we Deutsche Bank AG, Mumbai Branch acting in our capacity as the onshore security agent in respect of the Facility (as defined in the Earlier Disclosure 1), made a disclosure in respect of the encumbrance by way of pledge over the 238,663,700 equity shares of the issued and paid-up share capital of Piramal Pharma Limited (“Target Company”) constituting 17.93% of the issued and paid-up share capital (on a fully diluted basis) and 18.01% of the total voting capital of the Target Company. Chairman of the Supervisory Board: Alexander R. Wynaendts Management Board: Christian Sewing (Chairman), Fabrizio Campelli, Raja Akram, Marcus Chromik, Marie-Jeanne Deverdun, Stefan Hoops, Alexander von zur Mühlen, Laura Padovani, Claudio de Sanctis, Rebecca Short Deutsche Bank Aktiengesellschaft domiciled in Frankfurt am Main (incorporated in the Federal Republic of Germany and members’ liability is limited); Local Court of Frankfurt am Main, HRB No 30 000; VAT ID No DE114103379; www.db.com In the Earlier Disclosure 2, we Deutsche Bank AG, Mumbai Branch acting in our capacity as the onshore security agent in respect of the Facility (as defined in the Earlier Disclosure 1), made a disclosure in respect Released Shares (as defined in the Earlier Disclosure 2). Now, the Borrower has re-created a pledge over 98,400,000 equity shares of the issued and paid-up share capital of the Target Company, constituting 7.39% of the total issued and paid-up share capital of the Target Company (on a fully diluted basis) and 7.43% of the total voting capital of the Target Company (“Repledged Shares”). After such re-creation of pledge, the Onshore Security Agent holds a pledge over 238,663,700 equity shares of the issued and paid-up share capital of the Target Company constituting 17.93% of the issued and paid-up share capital (on a fully diluted basis) and 18.01% of the total voting capital of the Target Company (“Pledged Shares”). This disclosure is being made by the Onshore Security Agent in respect of creation of encumbrance over the Repledged Shares. We also wish to clarify that as at the date of this disclosure, we do not hold any beneficial interest in the Pledged Shares and the Pledged Shares have been pledged in our favour in our capacity as pledgee. We request you to take the same on record and acknowledge the same. Signature of Authorised Signatory Name: RAMANATHAPURA, Prasanna Venkatesha Murthy Manu Designation: Vice President Place: Deutsche Bank AG, Hong Kong Branch Date: 26 August 2026 Chairman of the Supervisory Board: Alexander R. Wynaendts Management Board: Christian Sewing (Chairman), Fabrizio Campelli, Raja Akram, Marcus Chromik, Marie-Jeanne Deverdun, Stefan Hoops, Alexander von zur Mühlen, Laura Padovani, Claudio de Sanctis, Rebecca Short Deutsche Bank Aktiengesellschaft domiciled in Frankfurt am Main (incorporated in the Federal Republic of Germany and members’ liability is limited); Local Court of Frankfurt am Main, HRB No 30 000; VAT ID No DE114103379; www.db.com Disclosure under Regulation 29(2) of SEBl (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) Piramal Pharma Limited Name(s) of the acquirer and Deutsche Bank AG, Mumbai Branch acting in its capacity as the onshore Persons Acting in Concert (PAC) security agent for Lenders (as defined in the Earlier Disclosure) to CA with the acquirer Alchemy Investments under the Facility Agreement (as defined in the Earlier Disclosure) Deutsche Bank AG, Singapore Branch DBX Advisors LLC Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) BSE Limited and National Stock Exchange of India Limited where the shares of TC are Listed % w.r.t. total % w .r.t. total diluted Details of the acquisition as share/voting share/voting Number follows capital wherever capital of the TC applicable(*) (**) Before the acquisition under 1,317 0.00% of total 0.00% of total consideration, holding of: share capital / share capital / 0.00% 0.00% of voting of voting capital # capital # (a) Shares carrying voting rights (b) Shares in the nature of 238,663,700# 17.93% of total 17.93% of total encumbrance (pledge/ share capital / share capital / lien/ non-disposal 18.01% of 18.01% of voting undertaking/ others) voting capital # capital # (c) Voting rights (VR) otherwise Nil Nil Nil than by shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) (e) Total (a+b+c+d) 238,665,017# 17.93% of total 17.93% of total share capital / share capital / 18.01% of 18.01% of voting voting capital # capital # Details of acquisition Nil Nil Nil (a) Shares carrying voting rights acquired / sold (b) VRs acquired otherwise than Nil Nil Nil by shares (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/ sold (d) Shares encumbered/ invoked/ 98,400,000# 7.39% of total 7.39% of total released by the acquirer share capital / share capital / 7.43% 7.43% of voting of voting capital (See Note #) capital (e) Total (a+b+c+/-d) 98,400,000# 7.39% of total 7.39% of total share capital / share capital / 7.43% 7.43% of voting of voting capital capital After the acquisition/ sale, 1,317 0.00% of total 0.00% of total holding of: share capital / share capital / 0.00% 0.00% of voting of voting capital # (a) Shares carrying voting rights capital # (b) Shares encumbered with the 238,663,700# 17.93% of total 17.93% of total acquirer share capital / share capital / 18.01% of 18.01% of voting voting capital # capital # (b) VRs otherwise than by shares Nil Nil Nil (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition (d) Total (a+b+c+d) 238,665,017# 17.93% of total 17.93% of total share capital / share capital / 18.01% of 18.01% of voting voting capital # capital # Mode of acquisition (e.g. open Creation of encumbrance. Please see note # below. market/ off-market/public issue/rights issue/preferential allotment/inter se transfer/ etc.) Date of acquisition/ sale of shares / 24 August 2026 (date of creation of encumbrance) VR or date of receipt of intimation of allotment of shares, whichever is applicable. Equity share capital / total voting 1,331,348,130 shares/ 1,325,018,448 voting shares of INR 10 each capital of the TC before the said acquisition / sale Equity share capital/ total voting 1,331,348,130 shares/ 1,325,018,44 [Showing first 8,000 characters — download PDF for full document]